Nuclear localization of KLF4 was found to be a prognostic factor correlating to aggressive phenotype in breast cancers, and knockdown of KLF4 in breast cancer cells induces p53-dependent cell apoptosis, which is consistent with an anti-apoptotic function of KLF4 (refs 1, 2). Here, TP53 is linked to breast carcinoma.